Some Cancer Patients Might Safely Skip Radiation Therapy
New clinical trials show radiation therapy might not be necessary in treating some forms of rectal cancer and lymphoma, sparing patients from the toxic treatment. (Source: WebMD Health)
Source: WebMD Health - June 6, 2023 Category: Consumer Health News Source Type: news
Some Cancer Patients Might Safely Skip Radiation Therapy
New clinical trials shows radiation therapy might not be necessary in treating some forms of rectal cancer and lymphoma, sparing patients from the toxic treatment. (Source: WebMD Health)
Source: WebMD Health - June 6, 2023 Category: Consumer Health News Source Type: news
Many With Relapsed/Refractory Lymphoma in Pregnancy Delay Treatment
TUESDAY, June 6, 2023 -- Most women with relapsed/refractory lymphoma during pregnancy defer therapy and there are few obstetric or neonatal complications, according to a study published online June 1 in Blood Advances.
Faheem Farooq, M.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 6, 2023 Category: Pharmaceuticals Source Type: news
Can Some Cancer Patients Safely Skip Radiation Therapy? New Studies Say Yes
TUESDAY, June 6, 2023 -- Radiation therapy might not be necessary in treating some forms of rectal cancer and lymphoma, sparing patients from the toxic treatment, a pair of new clinical trials shows.
One trial found that rectal cancer patients... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 6, 2023 Category: General Medicine Source Type: news
Opdivo Could Boost Outcomes for People Battling Hodgkin Lymphoma
TUESDAY, July 6, 2023 -- The widely used immunotherapy drug nivolumab (Opdivo) is safer and more effective in treating adults and children with advanced Hodgkin lymphoma than the targeted therapy now used as standard care is, new clinical trial... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 6, 2023 Category: General Medicine Source Type: news
Woman who thought bouts of dizziness at the gym finds out it was symptom of stage four lymphoma
Taylor Davis, 26, from San Diego, California, was diagnosed with stage four lymphoma, a type of cancer affecting white blood cells. She is now in remission but needs regular check-ups. (Source: the Mail online | Health)
Source: the Mail online | Health - June 6, 2023 Category: Consumer Health News Source Type: news
Second-Line Axi-Cel Bests Standard in Relapsed/Refractory Large B-Cell Lymphoma
(MedPage Today) -- CHICAGO -- Patients treated with the chimeric antigen receptor (CAR) T-cell therapy axicabtagene ciloleucel (axi-cel; Yescarta) in the second line for early relapsed or refractory large B-cell lymphoma had significantly longer... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - June 5, 2023 Category: Hematology Source Type: news
Groundbreaking New Regimen for Advanced Hodgkin Lymphoma Groundbreaking New Regimen for Advanced Hodgkin Lymphoma
Nivolumab instead of brentuximab added onto chemotherapy is suggested as the new standard of care, based on results from the largest Hodgkin lymphoma study in National Clinical Trials Network history.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 5, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
ASCO: Seagen's top-selling drug under threat as Bristol Myers' Opdivo beats Adcetris in lymphoma
The rising antibody-drug conjugate class has hit a setback as Seagen’s Adcetris, one of the earliest and fast-growing members of the group, was defeated by immune checkpoint inhibitor. | The rising antibody-drug conjugate class has hit a setback as Seagen’s Adcetris, one of the earliest and…#seagen #adcetris (Source: Reuters: Health)
Source: Reuters: Health - June 4, 2023 Category: Consumer Health News Source Type: news
Nivolumab-AVD Boosts PFS in Untreated Hodgkin Lymphoma
(MedPage Today) -- CHICAGO -- Adding the immune checkpoint inhibitor nivolumab (Opdivo), rather than brentuximab vedotin (Adcetris), to a standard chemotherapy backbone reduced the risk of disease progression or death in newly diagnosed adults... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - June 4, 2023 Category: Hematology Source Type: news
ISMRM: PET/MRI adds value in clinical cancer imaging
TORONTO - Hybrid PET/MRI imaging could eventually serve as a "one-stop shop...Read more on AuntMinnie.comRelated Reading:
PET/MRI cuts breast cancer scan times in half
PET/MRI shows heart inflammation after COVID-19 vaccination
PET/MRI an effective alternative to PET/CT for lymphoma management
Brain PET/MRI scans reveal visual snow syndrome
Pylarify PET/MRI shows value in selecting patients for focal ablative therapy (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 4, 2023 Category: Radiology Source Type: news
What to Do When Tough-to-Treat Lymphoma Strikes During Pregnancy
FRIDAY, June 2, 2023 -- Not a lot is known about how physicians should handle cases in which a pregnant woman is diagnosed with relapsed/refractory lymphoma.
A new study may provide some perspective.
Though uncommon, this issue is still experienced... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 2, 2023 Category: General Medicine Source Type: news
Patient With Blood Cancer Takes on Bias and'Gaslighting'Patient With Blood Cancer Takes on Bias and'Gaslighting '
After having her concerns dismissed by her doctor, a woman diagnosed with Hodgkin lymphoma partnered with the Lymphoma Research Foundation to spread the word about unique challenges facing patients.MDedge News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 1, 2023 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
I thought I was just tired, then doctors told me I had cancer and a 15% chance of survival
Michael Cramer, 21, from Miami, Florida (shown left, right, and inset with father and brother) was diagnosed with lymphoma in 2020 after having flu-like symptoms, such as fatigue and lack of appetite. (Source: the Mail online | Health)
Source: the Mail online | Health - May 31, 2023 Category: Consumer Health News Source Type: news
Episode 6: Bruton Tyrosine Kinase Inhibitors in Mantle Cell Lymphoma Episode 6: Bruton Tyrosine Kinase Inhibitors in Mantle Cell Lymphoma
Drs Peter Martin and Anita Kumar discuss covalent and noncovalent Bruton tyrosine kinase (BTK) inhibitors in the frontline setting, BTK mutations, and the complicated mechanisms of resistance.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 31, 2023 Category: Consumer Health News Tags: Hematology-Oncology InDiscussion Source Type: news
